JMP Securities Starts Ocular Therapeutix (OCUL) at Market Outperform
JMP Securities initiated coverage on Ocular Therapeutix (NASDAQ: OCUL) with a Market Outperform rating and a price target of $21.00.
For an analyst ratings summary and ratings history on Ocular Therapeutix click here. For more ratings news on Ocular Therapeutix click here.
Shares of Ocular Therapeutix closed at $5.84 yesterday.